Pharmaceutical Industry Information Portal

HomeDiscovery and Development

Discovery and Development

The combination between the AstraZeneca vaccine and the Sputnik Light shows no serious adverse events

In August 2021, RDIF and partners will publish initial data on the immunogenicity of the combined use of the AstraZeneca vaccine and the Sputnik V vaccine in Azerbaijan.

Delta strain may become standard for coronavirus vaccines, expert says

When developing new vaccines in the future, the basis of vaccines registered in Russia will probably be replaced with the Delta variant.

AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity

AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed against the GPR75 target with the potential...

Russian Health Ministry permits Biocad to conduct clinical trials of new COVID vaccine

The state registry notes that the trials will last until late 2026 and will involve 360 patients. The vaccine will be administered via an intramuscular injection.

Chemists Found an Effective Cure for Senile Brain Disease

The most effective compound was tested on living tissues of rats with secondary injuries after craniocerebral injuries.

Sputnik V vaccine effective against new variants of coronavirus

Sputnik V pioneered the vaccine cocktail approach with two shots. The tests conducted by the Gamaleya Center have demonstrated validity of this approach.
spot_img

Expert Articles

spot_img